SEC Form 4/A · accession 0001053369-15-000031
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeenarine Narine
Director
Period of report
Apr 1, 2014
Accepted (ET)
May 13, 2015 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2014 | S | 157,012 | $0.4116 | D | 5,830,544 | D | |
| Common StockF2 | Apr 2, 2014 | S | 147,667 | $0.41 | A | 5,682,877 | D | |
| Common StockF4,F3 | holding | — | — | — | 14,887,229 | I | by Epic Investments, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The original filing inadvertently did not include this transaction.
- F2The original filing inadvertently under reported the transaction by three shares.
- F3Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- F4Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.